Literature DB >> 34052875

Predictive value of anti-Müllerian hormone on pregnancy outcomes in in-vitro fertilization/intracytoplasmic single sperm injection patients at different ages.

Yujing Zhang1,2, Liling Wang1, Sijia Zhao1, Cuilian Zhang2, Qiaohua He3, Aihua Liao4.   

Abstract

PURPOSE: To investigate the predictive value of AMH level for pregnancy outcomes in different age groups of IVF/ICSI patients.
METHODS: The study was a cohort study that included 11,484 patients that had their first IVF/ICSI procedure between 2016 and 2019. All patients who met the inclusion and exclusion criteria were divided into 6 groups according to 5-year age intervals, namely, Group 1: 20-24 years (n = 725); Group 2: 25-29 years (n = 4019); Group 3: 30-34 years (n = 3600); Group 4: 35-39 years (n = 1915); Group 5: 40-44 years (n = 1006); and Group 6: ≥ 45 years (n = 219).
RESULTS: Receiver operating characteristic (ROC) curve analysis revealed that AMH level could only predict the outcome of live birth in Group 3 and Group 4 (p < 0.05). The area under the curve (AUC) of Group 3 was 0.536 (95% CI 0.510-0.561, p = 0.006), and that of Group 4 was 0.562 (95% CI 0.527-0.598, p = 0.001). The cutoff values of AMH for predicting live birth in Group 3 and Group 4 were 1.84 ng/ml and 1.86 ng/ml, respectively. Further logistic regression analysis showed that only the cutoff values of AMH and age could predict live birth in Groups 3 and 4.
CONCLUSIONS: AMH level could predict live birth in IVF/ICSI patients at the age of 30-39. However, it could not be used to predict live birth in patients < 30 years or ≥ 40 years.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Anti-Müllerian hormone; In vitro fertilization; Intracytoplasmic single sperm injection; Live birth; Reproductive aging

Mesh:

Substances:

Year:  2021        PMID: 34052875     DOI: 10.1007/s00404-021-06108-5

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  35 in total

Review 1.  Anti-Müllerian hormone and folliculogenesis.

Authors:  Jenny A Visser; Axel P N Themmen
Journal:  Mol Cell Endocrinol       Date:  2005-04-29       Impact factor: 4.102

2.  Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.

Authors:  Talia Eldar-Geva; Avraham Ben-Chetrit; Irving M Spitz; Ron Rabinowitz; Einat Markowitz; Tzvia Mimoni; Michael Gal; Edit Zylber-Haran; Ehud J Margalioth
Journal:  Hum Reprod       Date:  2005-08-19       Impact factor: 6.918

3.  Relevance of anti-Mullerian hormone measurement in a routine IVF program.

Authors:  C Gnoth; A N Schuring; K Friol; J Tigges; P Mallmann; E Godehardt
Journal:  Hum Reprod       Date:  2008-04-02       Impact factor: 6.918

Review 4.  A systematic review of tests predicting ovarian reserve and IVF outcome.

Authors:  F J Broekmans; J Kwee; D J Hendriks; B W Mol; C B Lambalk
Journal:  Hum Reprod Update       Date:  2006-08-04       Impact factor: 15.610

Review 5.  AMH: An ovarian reserve biomarker in assisted reproduction.

Authors:  C Peluso; F L A Fonseca; I F Rodart; V Cavalcanti; G Gastaldo; D M Christofolini; C P Barbosa; B Bianco
Journal:  Clin Chim Acta       Date:  2014-07-30       Impact factor: 3.786

6.  Normal serum concentrations of anti-Müllerian hormone in women with regular menstrual cycles.

Authors:  A La Marca; G Sighinolfi; S Giulini; M Traglia; C Argento; C Sala; C Masciullo; A Volpe; D Toniolo
Journal:  Reprod Biomed Online       Date:  2010-05-24       Impact factor: 3.828

7.  Low antimüllerian hormone (AMH) is associated with decreased live birth after in vitro fertilization when follicle-stimulating hormone and AMH are discordant.

Authors:  Sarah Ligon; Michael Lustik; Gary Levy; Bruce Pier
Journal:  Fertil Steril       Date:  2019-05-02       Impact factor: 7.329

8.  Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.

Authors:  Eman A Elgindy; Dahlia O El-Haieg; Azza El-Sebaey
Journal:  Fertil Steril       Date:  2007-07-20       Impact factor: 7.329

9.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

Authors:  Christien Weenen; Joop S E Laven; Anne R M Von Bergh; Mark Cranfield; Nigel P Groome; Jenny A Visser; Piet Kramer; Bart C J M Fauser; Axel P N Themmen
Journal:  Mol Hum Reprod       Date:  2004-02       Impact factor: 4.025

10.  Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach.

Authors:  Simone L Broer; Jeroen van Disseldorp; Kimiko A Broeze; Madeleine Dolleman; Brent C Opmeer; Patrick Bossuyt; Marinus J C Eijkemans; Ben-Willem J Mol; Frank J M Broekmans
Journal:  Hum Reprod Update       Date:  2012-11-27       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.